552 related articles for article (PubMed ID: 11323136)
1. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.
Bennett M
Pain; 2001 May; 92(1-2):147-57. PubMed ID: 11323136
[TBL] [Abstract][Full Text] [Related]
2. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
Bennett MI; Smith BH; Torrance N; Potter J
J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
[TBL] [Abstract][Full Text] [Related]
3. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
[TBL] [Abstract][Full Text] [Related]
4. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
Barbosa M; Bennett MI; Verissimo R; Carvalho D
Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
[TBL] [Abstract][Full Text] [Related]
5. Development of the Japanese Version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale: Diagnostic Utility in a Clinical Setting.
Isomura T; Sumitani M; Matsudaira K; Kawaguchi M; Inoue R; Hozumi J; Tanaka T; Oshima H; Mori K; Taketomi S; Inui H; Tahara K; Yamagami R; Hayakawa K
Pain Pract; 2017 Jul; 17(6):800-807. PubMed ID: 27770598
[TBL] [Abstract][Full Text] [Related]
6. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing.
Gierthmühlen J; Schneider U; Seemann M; Freitag-Wolf S; Maihöfner C; Enax-Krumova EK; Azad SC; Üçeyler N; Birklein F; Maier C; Tölle T; Treede RD; Baron R
Pain; 2019 Sep; 160(9):2093-2104. PubMed ID: 31162335
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
Koc R; Erdemoglu AK
Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
[TBL] [Abstract][Full Text] [Related]
10. Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study.
Yucel A; Senocak M; Kocasoy Orhan E; Cimen A; Ertas M
J Pain; 2004 Oct; 5(8):427-32. PubMed ID: 15501424
[TBL] [Abstract][Full Text] [Related]
11. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
[TBL] [Abstract][Full Text] [Related]
12. Can the LANSS scale be used to classify pain in chronic cancer pain trials?
Hardy J; Quinn S; Fazekas B; Agar M; Currow D
Support Care Cancer; 2013 Dec; 21(12):3387-91. PubMed ID: 23934225
[TBL] [Abstract][Full Text] [Related]
13. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study.
Hans G; Masquelier E; De Cock P
BMC Public Health; 2007 Jul; 7():170. PubMed ID: 17650299
[TBL] [Abstract][Full Text] [Related]
15. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
[TBL] [Abstract][Full Text] [Related]
16. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
Garoushi S; Johnson MI; Tashani OA
Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Screening Tool for Surgery-Specific Neuropathic Pain: Neuropathic Pain Scale for Postsurgical Patients.
Mejdahl MK; Christoffersens KB; Andersen KG
Pain Physician; 2019 Mar; 22(2):E81-E90. PubMed ID: 30921980
[TBL] [Abstract][Full Text] [Related]
18. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
[TBL] [Abstract][Full Text] [Related]
19. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
Walker SM; Peters J; Verriotis M; Farag F; Jay MA; Howard RF
J Pain; 2024 Feb; 25(2):451-465. PubMed ID: 37741521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
